http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101124796-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-32 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2009-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101124796-B1 |
| titleOfInvention | Donepezil Resin Complex |
| abstract | The present invention provides a donepezil resin complex consisting of donepezil or a pharmaceutically acceptable salt and a cation exchange resin and an oral administration agent comprising the same.n n n The complex of the present invention can effectively mask the unpleasant taste of donepezil or its salt, and has the advantage of being formulated in various formulations such as chewable tablets, orally disintegrating tablets, troche tablets or suspensions.n n n n Donepezil, cation exchange resin |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200064951-A |
| priorityDate | 2009-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.